This study aimed to correlate serum uric acid levels and PAH in OSAHS patients.

Obstructive sleep apnea-hypopnea syndrome is the most common form of SRBDs. Recurrent hypoxia, that accompanies OSAHS increases the degradation of ATP, which in turn increase uric acid concentration that can be used as a biomarker of tissue hypoxia in OSAHS. There is still debate about whether OSAHS is an independent contributor to pulmonary arterial hypertension.

AIM OF THE WORK This study aimed to correlate serum uric acid levels and PAH in OSAHS patients. Methods We enrolled 100 patients diagnosed with OSAHS using polysomnography. Patients were divided into three severity groups: mild OSA (5 ≤ AHI < 15), moderate OSA (15 ≤ AHI < 30), and severe (30 ≤ AHI < 60). Serum uric acid was measured the morning after polysomnography. All patients underwent standard echocardiograms, and Pulmonary artery systolic pressure calculation was done.

Inclusion Criteria:

• Clinical diagnosis of OSAHS by overnight polysomnography (AHI ≥ 5/ hr)
• ≥18 years old.

Exclusion Criteria:

• Other sleep disorders as narcolepsy or hypersomnia were excluded as well as Patients with neuropsychiatric disorders.
• Hemodynamically unstable patients
• Patients with other chronic respiratory or cardiac diseases
• Patients with other known causes of pulmonary hypertension
• Patients with any disease or on medication that could alter excretion or urinary metabolism of uric acid such as Excessive uric acid production